SCHEMBL29567259

SCHEMBL29567259

Cc1ccccc1-c1nc(NS(=O)(=O)c2cnn(C)c2)nc(Oc2ccc(N3CCNCC3)cc2)c1C

nearest known ligand 0.39

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 3/20 0.39
▸ RIPK2 O43353 5/20 0.37
▸ ACVR1 Q04771 5/20 0.37
▸ NOD2 Q9HC29 5/20 0.37
▸ EGFR P00533 1/20 0.37
▸ LCK P06239 1/20 0.37
▸ JAK3 P52333 1/20 0.37
▸ BTK Q06187 1/20 0.37
▸ TNK2 Q07912 1/20 0.37
▸ LTA4H P09960 1/20 0.36
▸ GUSB P08236 1/20 0.34
▸ FLT3 P36888 1/20 0.34
▸ HTR1A P08908 3/20 0.34
▸ HTR7 P34969 3/20 0.34
▸ IGF1R P08069 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309725 1.00 HTR6 (0.39) HTR6RIPK2ACVR1NOD2EGFR
SCHEMBL24309903 0.92 NOD2 (0.39) HTR6RIPK2ACVR1NOD2EGFR
SCHEMBL29566801 0.92 NOD2 (0.39) HTR6RIPK2ACVR1NOD2EGFR
SCHEMBL29567089 0.92 HTR6 (0.37) HTR6RIPK2ACVR1NOD2EGFR
SCHEMBL24310067 0.92 HTR6 (0.37) HTR6RIPK2ACVR1NOD2EGFR
SCHEMBL24309861 0.87 HTR1A (0.40) EGFRHTR1AHTR7KDM4E
SCHEMBL29567228 0.87 HTR1A (0.40) EGFRHTR1AHTR7KDM4E
SCHEMBL24310024 0.87 LCK (0.36) HTR6RIPK2ACVR1NOD2EGFR
SCHEMBL29567116 0.87 LCK (0.36) HTR6RIPK2ACVR1NOD2EGFR
SCHEMBL29566726 0.85 RIPK2 (0.39) HTR6RIPK2ACVR1NOD2EGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback